Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke
- PMID: 12843350
- DOI: 10.1161/01.STR.0000080941.73934.30
Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke
Abstract
Background and purpose: Thrombin-induced clots used in experimental thromboembolic stroke differ from clots forming spontaneously under clinical conditions. We investigated whether this difference influences the efficacy and outcome of thrombolytic treatment.
Methods: In rats, the middle cerebral artery was occluded by intracarotid injection of fibrin-rich clots, prepared either according to established methods by adding thrombin to freshly drawn arterial blood or by spontaneous coagulation. The mechanical properties of clots were determined in vitro by elasticity and plasticity tests. One hour after embolism, thrombolysis was started by intra-arterial application of recombinant tissue plasminogen activator (rtPA) (10 mg/kg). Treatment efficacy was monitored by MR measurements of blood perfusion, apparent diffusion coefficient (ADC), T2 relaxation time and blood-brain barrier permeability, and by pictorial measurements of ATP and pH.
Results: Thrombin-induced clots were classified as elastic, and spontaneously forming clots were classified as plastic. Middle cerebral artery embolism with thrombin-induced or spontaneously forming clots led to similar reduction of perfusion and ADC, but rtPA treatment efficacy differed greatly. In the spontaneously forming clot group, blood perfusion returned to or above control within 2 hours, ADC and ATP normalized, tissue pH exhibited alkalosis, and T2 and blood-brain barrier permeability did not change. In the thrombin-induced clot group, in contrast, blood reperfusion was delayed, ADC and ATP remained reduced, tissue pH was acidic, and edema developed, as reflected by increased T2 and blood-brain barrier permeability.
Conclusions: rtPA-induced thrombolysis promotes rapid reperfusion and tissue recovery in animals embolized with spontaneously forming clots but not in those embolized with thrombin-induced clots. This difference is explained by the different mechanical and possibly molecular consequences of clot preparation and must be considered for the interpretation of thrombolysis experiments.
Similar articles
-
Thrombolytic treatment of clot embolism in rat: comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator.Stroke. 2002 Dec;33(12):2999-3005. doi: 10.1161/01.str.0000038096.60932.f4. Stroke. 2002. PMID: 12468803
-
Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.J Cereb Blood Flow Metab. 1998 Apr;18(4):407-18. doi: 10.1097/00004647-199804000-00009. J Cereb Blood Flow Metab. 1998. PMID: 9538906
-
A translationally relevant thromboembolic stroke model for the study of secondary hemorrhage after thrombolysis in rats.Brain Res. 2011 Jan 12;1368:346-54. doi: 10.1016/j.brainres.2010.10.067. Epub 2010 Oct 23. Brain Res. 2011. PMID: 20974110
-
Thrombolytic therapy in experimental embolic stroke.Cerebrovasc Brain Metab Rev. 1994 Fall;6(3):257-86. Cerebrovasc Brain Metab Rev. 1994. PMID: 7811566 Review.
-
A novel mouse model of thromboembolic stroke.J Neurosci Methods. 2015 Dec 30;256:203-11. doi: 10.1016/j.jneumeth.2015.09.013. Epub 2015 Sep 18. J Neurosci Methods. 2015. PMID: 26386284 Free PMC article. Review.
Cited by
-
Animal models of stroke.Animal Model Exp Med. 2021 Sep 15;4(3):204-219. doi: 10.1002/ame2.12179. eCollection 2021 Sep. Animal Model Exp Med. 2021. PMID: 34557647 Free PMC article. Review.
-
Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat.J Neurosci Methods. 2012 Nov 15;211(2):296-304. doi: 10.1016/j.jneumeth.2012.09.006. Epub 2012 Sep 14. J Neurosci Methods. 2012. PMID: 22985597 Free PMC article.
-
Factors Influencing Recanalization After Mechanical Thrombectomy With First-Pass Effect for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.Front Neurol. 2021 Apr 9;12:628523. doi: 10.3389/fneur.2021.628523. eCollection 2021. Front Neurol. 2021. PMID: 33897591 Free PMC article.
-
Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke.PLoS One. 2014 Jun 9;9(6):e98807. doi: 10.1371/journal.pone.0098807. eCollection 2014. PLoS One. 2014. PMID: 24911517 Free PMC article.
-
Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.Exp Neurol. 2008 Sep;213(1):196-201. doi: 10.1016/j.expneurol.2008.05.022. Epub 2008 Jun 9. Exp Neurol. 2008. PMID: 18590727 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical